自身免疫性肝脏疾病
上QQ阅读APP看书,第一时间看更新

参考文献

1.Kita H,Mackay IR,Van De Water J,et al. The lymphoid liver:considerations on pathways to autoimmune injury.Gastroenterology,2001,120:1485-1501.
2.Mackay IR. Hepatoimmunology:a perspective. Immunol Cell Biol,2002,80:36-44.
3.Sheth K,Bankey P. The liver as an immune organ. Curr Opin Crit Care,2001,7:99-104.
4.Wick MJ,Leithauser F,Reimann J. The hepatic immune system. Crit Rev Immunol,2002,22:47-103.
5.Doherty DG,O’ Farrelly C. Innate and adaptive lymphoid cells in the human liver. Immunol Rev,2000,174:5-20.
6.Kawasaki T,Kawai T Toll-like receptor signaling pathways. FrontImmunol,2014,5:461.
7.Chen IY,Ichinohe T. Response of host inflammasomes to viral infection. Trends Microbiol,2014.
8.Lau AH,Thomson AW. Dendritic cells and immune regulation in the liver. Gut,2003,52:307-314.
9.Limmer A,Ohl J,Wingender G,et al. Cross-presentation of oral antigens by liver sinusoidal endothelial cells leads to CD8 T cell tolerance. Eur J Immunol,2005,35:2970-2981.
10.Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol,2003,3:331-341.
11.Banchereau J,Steinman RM. Dendritic cells and the control of immunity. Nature,1998,392:245-252.
12.Bertolino P,Klimpel G,Lemon SM. Hepatic inflammation and immunity:a summary of a conference on the function of the immune system within the liver. Hepatology,2000,31:1374-1378.
13.Cooper MA,Fehniger TA,Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol,2001,22:633-640.
14.Zingoni A,Ardolino M,Santoni A,et al. NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions:role in the NK cell-mediated negative regulation of T cell responses. Front Immunol,2012,3:408.
15.Exley MA,Koziel MJ. To be or not to be NKT:natural killer T cells in the liver. Hepatology,2004,40:1033-1040.
16.Porcelli SA,Modlin RL. The CD1 system:antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol,1999,17:297-329.
17.Kinjo Y,Wu D,Kim G,et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature,2005,434:520-525.
18.Kakimi K,Guidotti LG,Koezuka Y,et al. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med,2000,192:921-930.
19.Reinhardt RL,Khoruts A,Merica R,et al. Visualizing the generation of memory CD4 T cells in the whole body.Nature,2001,410:101-105.
20.Thimme R,Bukh J,Spangenberg HC,et al. Viral and immunological determinants of hepatitis C virus clearance,persistence,and disease. Proc Natl Acad Sci U S A,2002,99:15661-15668.
21.Murphy KM,Reiner SL. The lineage decisions of helper T cells. Nat Rev Immunol,2002,2:933-944.
22.Kolls JK,Linden A. Interleukin-17 family members and inflammation. Immunity,2004,21:467-476.
23.Lan RY,Ansari AA,Lian ZX,et al. Regulatory T cells:development,function and role in autoimmunity. Autoimmun Rev,2005,4:351-363.
24.Bettelli E,Carrier Y,Gao W,et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature,2006,441:235-238.
25.Lan RY,Cheng C,Lian ZX,et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology,2006,43:729-737.
26.Mangan PR,Harrington LE,O’Quinn DB,et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature,2006,441:231-234.
27.Krawitt EL. Autoimmune hepatitis. N Engl J Med,2006,354:54-66.
28.Manns MP,Czaja AJ,Gorham JD,et al. Diagnosis and management of autoimmune hepatitis. Hepatology,2010,51:2193-2213.
29.Miao Q,Bian Z,Tang R,et al. Emperipolesis Mediated by CD8 T Cells Is a Characteristic Histopathologic Feature of Autoimmune Hepatitis. Clin Rev Allergy Immunol,2014.
30.Wang Q,Selmi C,Zhou X,et al. Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis. J Autoimmun,2013,41:140-145.
31.Bo X,Broome U,Remberger M,et al. Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis. Gut,2001,49:131-141.
32.Liu M,Zhang C. The Role of Innate Lymphoid Cells in Immune-Mediated Liver Diseases. Front Immunol.2017,8:695.
33.Doherty DG. Immunity,tolerance and autoimmunity in the liver:A comprehensive review. J Autoimmun,2016,66:60-75.
34.Trivedi PJ,Adams DH. Gut-liver immunity. J Hepatol,2016,64(5):1187-1189.
35.Shuai Z,Leung MW,He X,et al. Adaptive immunity in the liver. Cell Mol Immunol,2016,13(3):354-368.
36.van Gerven NM,de Boer YS,Mulder CJ,et al. Auto immune hepatitis. World J Gastroenterol,2016,22(19):4651-4661.
37.Liberal R,Krawitt EL,Vierling JM,et al. Cutting edge issues in autoimmune hepatitis. J Autoimmun,2016,75:6-19.